UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gw572016 (17) 17
humans (13) 13
lapatinib (12) 12
breast cancer (10) 10
egfr (10) 10
life sciences & biomedicine (10) 10
science & technology (10) 10
quinazolines - therapeutic use (8) 8
female (7) 7
her2 (7) 7
biological and medical sciences (6) 6
breast neoplasms - drug therapy (6) 6
medical sciences (6) 6
pharmacology & pharmacy (6) 6
antineoplastic agents (5) 5
antineoplastic agents - therapeutic use (5) 5
oncology (5) 5
pharmacology. drug treatments (5) 5
quinazolines - pharmacokinetics (5) 5
quinazolines - pharmacology (5) 5
receptor, erbb-2 - antagonists & inhibitors (5) 5
antimitotic agents (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cancer (4) 4
clinical trials as topic (4) 4
dual tyrosine kinase inhibitor (4) 4
erbb2 (4) 4
protein kinase inhibitors - therapeutic use (4) 4
quinazolines - adverse effects (4) 4
research (4) 4
signal transduction (4) 4
trastuzumab (4) 4
tumors (4) 4
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
breast neoplasms - metabolism (3) 3
chemotherapy (3) 3
dosage and administration (3) 3
gefitinib (3) 3
gynecology. andrology. obstetrics (3) 3
her-2 (3) 3
mammary gland diseases (3) 3
metastasis (3) 3
metastatic breast cancer (3) 3
neoplasms - drug therapy (3) 3
receptor protein-tyrosine kinases - antagonists & inhibitors (3) 3
receptor, epidermal growth factor - antagonists & inhibitors (3) 3
tyrosine (3) 3
tyrosine kinase inhibitor (3) 3
animals (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic agents - pharmacokinetics (2) 2
area under curve (2) 2
breast neoplasms - pathology (2) 2
capecitabine (2) 2
care and treatment (2) 2
cell line, tumor - drug effects (2) 2
ci-1033 (2) 2
complications and side effects (2) 2
drug resistance, neoplasm (2) 2
enzyme inhibitors (2) 2
epidermal growth factor (2) 2
erbb-2 (2) 2
erbb1 (2) 2
erlotinib (2) 2
health aspects (2) 2
internal medicine (2) 2
medical education (2) 2
medicine & public health (2) 2
oncology, experimental (2) 2
protein kinase inhibitors - adverse effects (2) 2
protein kinase inhibitors - pharmacokinetics (2) 2
proteins (2) 2
quinazolines - administration & dosage (2) 2
radiotherapy (2) 2
skin and connective tissue diseases (2) 2
administration, oral (1) 1
adolescent (1) 1
adult (1) 1
adverse events (1) 1
akt (1) 1
analysis (1) 1
analytical, structural and metabolic biochemistry (1) 1
ancer treatment (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - physiology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
apoptosis - drug effects (1) 1
binding sites (1) 1
biochemical research methods (1) 1
biochemistry & molecular biology (1) 1
bms 247550 (1) 1
breast neoplasms - enzymology (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - radiotherapy (1) 1
cancer therapies (1) 1
cell cycle - drug effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Therapeutics and clinical risk management, ISSN 1176-6336, 2007, Volume 3, Issue 4, pp. 665 - 673
Journal Article